Masimo | MASI - Выручка от реализации

Биржевая цена
178.51
Изменение за день
0 0%
Ежемесячно
0.67%
Ежегодный
10.90%
Q2 прогноз
174.81




Продажи Изменить Дата
Abbott USD 11.16B 300M 2026-03
Accuray USD 116.17M 14.63M 2024-12
Align Technology USD 1.05B 54.3M 2025-12
AngioDynamics USD 79.43M 3.72M 2025-09
Artivion USD 115.99M 2.6M 2025-12
AtriCure USD 140.5M 6.2M 2025-12
Avanos Medical USD 180.9M 3.1M 2025-12
Baxter International USD 2.97B 130M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Boston Scientific USD 5.2B 90M 2026-03
Dexcom USD 1.26B 50M 2025-12
Edwards Lifesciences USD 1.65B 80M 2026-03
General Electric Aerospace USD 11.6B 270M 2026-03
Globus Medical USD 826.4M 57.4M 2025-12
Haemonetics USD 338.97M 11.97M 2025-12
Inogen USD 74.93M 504K 2024-09
Insulet USD 783.8M 77.5M 2025-12
Integra LifeSciences USD 434.9M 32.84M 2025-12
Intuitive Surgical USD 2.77B 100M 2026-03
Masimo USD 412.5M 41M 2025-12
Medtronic USD 9B 39M 2026-01
Orthofix International USD 219.91M 14.28M 2025-12
Owens Minor USD 708.97M 11.71M 2025-12
ResMed USD 1.4B 100M 2025-12
Steris USD 1.5B 470M 2025-12
Stryker USD 7.2B 1.14B 2025-12
Tandem Diabetes Care USD 290.4M 41.15M 2025-12
Teleflex USD 568.98M 344.02M 2025-12
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
Zimmer Biomet Holdings USD 2.09B 150M 2026-03